Direct answer
The GGTP test is a blood test that measures gamma-glutamyl transpeptidase, an enzyme concentrated in the liver and bile ducts. A raised GGTP suggests the liver or biliary system is being irritated, but the GGTP test is not specific to any single disease and cannot, on its own, identify the cause or exclude liver disease.
Key takeaways
- GGTP is sensitive but not specific: it rises in many liver, bile duct, alcohol-related, drug-related and metabolic conditions.
- Its main practical use is to confirm whether a raised alkaline phosphatase (ALP) is coming from the liver or from bone.
- A normal GGTP does not exclude liver disease: significant fibrosis or cirrhosis can exist with normal enzymes.
- A raised GGTP is not proof of alcohol use: obesity, diabetes, fatty liver, medicines and biliary disease all raise it.
- Reference ranges differ between laboratories, methods, sex and age; read the range printed on your own report.
At a glance
| Feature | Detail |
|---|---|
| What is measured | Gamma-glutamyl transpeptidase enzyme activity in blood serum |
| Sample | Small venous blood sample, usually from the arm |
| Fasting | Usually not required for GGTP alone; fasting may be asked for if done with lipids or glucose, follow your laboratory's instruction |
| Time for the blood draw | Typically a few minutes; total visit often 10-20 minutes including registration and waiting |
| Units | U/L (units per litre), also written IU/L |
| Usually ordered with | ALP, ALT (SGPT), AST (SGOT), bilirubin, albumin, as part of a liver function test (LFT) panel |
| What it cannot do | Cannot name a diagnosis, cannot grade fibrosis, cannot prove or disprove alcohol intake |
Also known as
- GGT test, gamma-GT, gamma GT test
- Gamma-glutamyl transferase / gamma-glutamyl transpeptidase
- Commonly asked for in India as part of the "LFT", "liver test", "liver enzyme test", or alongside SGPT and SGOT
What the GGTP test is
Gamma-glutamyl transpeptidase is an enzyme present on the surface of cells in many organs, liver, bile ducts, kidney, pancreas, intestine and spleen. The GGTP measured in blood, however, comes almost entirely from the liver and biliary tract. GGTP takes part in glutathione handling, which is one reason its production increases when liver cells are under oxidative or chemical stress.
When bile flow is obstructed or bile duct cells are irritated, GGTP production and release rise. This is why the GGTP test behaves as a "cholestatic" marker, it tends to rise more with bile duct problems than with pure liver-cell inflammation, where ALT (SGPT) usually rises more.
Why the GGTP test is done
- To source a raised ALP: if ALP is high and GGTP is also high, a hepatobiliary cause is likely. If ALP is high and GGTP is normal, a bone cause (or, in pregnancy, placental ALP) is more likely. This is the single most useful role of the GGTP test.
- To help characterise an abnormal liver panel: a cholestatic pattern (ALP and GGTP raised out of proportion to ALT/AST) points towards bile ducts, drug-induced cholestasis or infiltrative liver disease.
- To support an assessment of alcohol-related liver injury, usually together with AST:ALT ratio and clinical history, never as a stand-alone verdict.
- To monitor liver-related side effects of certain medicines, when the treating doctor has specified monitoring.
- To help interpret raised enzymes in people with suspected steatotic liver disease (SLD), including metabolic dysfunction-associated steatotic liver disease (MASLD, the term that replaced NAFLD) and MetALD, where both metabolic risk and alcohol contribute.
Who should get this test
- People with an isolated raised ALP on a routine panel.
- People with symptoms suggesting bile flow obstruction, yellowing of eyes or skin, dark urine, pale stools, itching, right upper abdominal pain.
- People being assessed for fatty liver / metabolic risk: raised waist circumference, type 2 diabetes, dyslipidaemia, hypertension. In South Asians, metabolic liver disease occurs at lower BMI than in many other populations.
- People on anti-tubercular therapy, antiepileptics, methotrexate, some antibiotics or antifungals, where the prescriber has asked for liver monitoring.
- People taking AYUSH, herbal, ayurvedic or gym/bodybuilding supplements who develop liver-related symptoms or abnormal enzymes, these are a recognised cause of drug-induced liver injury in India.
- People being assessed for alcohol-related liver disease, as part of a wider evaluation.
The GGTP test is not recommended as a general population screening test in an otherwise well person with no risk factors, because raised values in healthy people are common and frequently lead to anxiety and unnecessary investigation.
What the GGTP test cannot detect or exclude
- It cannot give a diagnosis. A raised GGTP tells you something is affecting the liver or bile ducts; it does not say what.
- A normal GGTP does not exclude liver disease. Chronic hepatitis B or C, MASLD with fibrosis, and even established cirrhosis can occur with normal or near-normal liver enzymes.
- It cannot measure fibrosis or scarring. Fibrosis assessment needs scores such as FIB-4 or elastography, and sometimes biopsy.
- It cannot prove alcohol consumption and cannot quantify how much a person drinks. It is not a legally or clinically reliable alcohol test.
- It cannot exclude alcohol-related liver injury either, some people with heavy intake have normal GGTP.
- It cannot locate an obstruction. Gallstones, strictures and tumours need imaging, ultrasound, MRCP or CT.
- It cannot detect liver cancer. GGTP is not a tumour marker and a normal value does not exclude a liver mass.
- It cannot assess liver synthetic function. That requires albumin, bilirubin, prothrombin time/INR.
A result that does not show an abnormality means nothing abnormal was identified on that test, at that time, not that disease has been excluded. If symptoms continue despite a normal GGTP, go back to your doctor.
Related but different tests
| Test | Question it answers | How it differs from GGTP |
|---|---|---|
| ALP (alkaline phosphatase) | Is there cholestasis or a bone process? | Rises in both liver and bone disease. GGTP is used to tell those apart; ALP alone cannot. |
| ALT (SGPT) | Are liver cells being injured? | More liver-specific for hepatocellular injury. GGTP is more sensitive but far less specific. |
| AST (SGOT) | Liver-cell injury, plus muscle and heart | Also rises after intense exercise or muscle injury. GGTP is not affected by muscle. |
| Bilirubin | Is bile pigment accumulating? Is there jaundice? | Measures pigment handling, not enzyme induction. GGTP can be high with normal bilirubin. |
| Full LFT panel | Overall pattern of liver injury and function | GGTP is one component; patterns matter more than any single value. |
| Ultrasound (USG) abdomen / sonography | Is there a structural problem, stones, duct dilatation, fatty change, mass? | Anatomical, not biochemical. Ultrasound fatty-liver grading is descriptive and operator-dependent, insensitive to mild fat, and says nothing about inflammation or fibrosis. |
| FIB-4 score / elastography | Is there significant fibrosis? | GGTP cannot stage fibrosis. Transient elastography and shear-wave elastography are distinct techniques with different thresholds. |
| MRCP | Where exactly is the bile duct obstruction? | Detailed biliary imaging; GGTP only suggests that a biliary process may be present. |
| Hepatitis B/C, hepatitis E serology | Is there a specific viral cause? | Cause-specific. GGTP never identifies a virus. Hepatitis E is a common cause of acute hepatitis in India. |
Which test comes first depends on the clinical problem. In painless jaundice, imaging of the biliary tree is usually prioritised. In an incidentally raised ALP, GGTP is often the immediate next step. In suspected viral hepatitis, serology leads. No single test is universally "first" or superior.
How to prepare
Preparation instructions are set by each laboratory and differ between units. Your own laboratory's or doctor's instruction takes precedence over anything written here.
- Fasting: GGTP alone usually does not need fasting. If the GGTP test is bundled with lipid profile or fasting glucose, the laboratory may ask for an overnight fast.
- Alcohol: alcohol intake in the days before testing can raise GGTP. Tell the doctor honestly about recent intake rather than trying to time the test around it, an accurate history helps interpretation more than an artificially low value.
- Medicines and supplements: bring a list of everything you take, including ayurvedic, herbal, homeopathic and gym supplements, and any recent anti-tubercular treatment. Do not stop, start or change any prescribed medicine to prepare for this test; speak to the prescriber first.
- Timing: take the test at the time your doctor has advised, particularly if it is being used for monitoring on treatment.
If you have diabetes on glucose-lowering treatment
If fasting has been requested for a combined panel, ask your treating doctor how to handle insulin or sulfonylurea doses before the fast, and carry a source of sugar in case of hypoglycaemia. Prolonged unplanned fasting is not safe on these medicines.
If you have advanced chronic kidney disease, heart failure or a fluid restriction
Do not increase your fluid intake for this blood test. No extra water loading is needed for a GGTP test, and additional fluid can be harmful if you have been given a fluid limit.
If you are pregnant
Blood sampling is straightforward in pregnancy. Interpretation differs: ALP rises physiologically in pregnancy because of placental ALP, while GGTP usually stays within or below the usual range. Tell the laboratory and your doctor that you are pregnant.
If the test is for a child
Reference values in newborns and infants are much higher than in adults and are age-dependent. Paediatric results must be read against a paediatric range and interpreted by a paediatrician; do not compare a child's value with an adult range.
What happens during the GGTP test
- Registration and consent: the request form is checked and identity confirmed.
- Sampling: a tourniquet is applied, the skin is cleaned, and a small blood sample is drawn from a vein in the arm. This usually takes a couple of minutes. You may feel a brief prick and some pressure.
- After the draw: firm pressure is applied over the site. Most people resume normal activity immediately.
- Analysis: serum is separated and GGTP activity measured on an automated analyser.
Total time in the collection room is usually short, often 10 to 20 minutes including waiting and paperwork, though this depends on how busy the unit is. Report availability varies between laboratories; ask your collection centre when your report will be ready.
Understanding your GGTP report
GGTP is reported in U/L (or IU/L). Reference ranges depend on the assay method, the laboratory, and on sex and age, values in men are typically higher than in women, and values in infants are far higher than in adults. Because of this variation, compare your number only with the reference interval printed on your own report, not with a range found online.
What matters clinically is the pattern and the degree of elevation, read alongside your symptoms and history:
- GGTP high with ALP high: suggests a hepatobiliary or cholestatic process, bile duct obstruction, drug-induced cholestasis, infiltrative liver disease.
- ALP high with GGTP normal: points away from the liver, towards bone (for example, vitamin D deficiency with bone turnover, Paget disease, healing fracture) or, in pregnancy, the placenta.
- GGTP high with ALT (SGPT) and AST (SGOT) high: suggests liver-cell injury with a cholestatic component, fatty liver, alcohol-related injury, viral hepatitis, drug injury.
- GGTP mildly high in isolation: extremely common and often not due to significant liver disease. It is frequently seen with metabolic risk factors, medicines, or as a normal individual variant, and usually prompts review of risk factors and a repeat rather than immediate extensive testing.
A number on a report is not a diagnosis. Your GGTP result must be interpreted in clinical context by the doctor who requested it.
When GGTP results can be misleading
Causes of a falsely raised or non-specifically raised GGTP
- Enzyme induction by medicines: phenytoin, phenobarbitone, carbamazepine and several other drugs increase GGTP production without necessarily causing liver damage.
- Recent alcohol intake, including a single heavy episode, can raise GGTP transiently, this does not indicate chronic liver disease.
- Metabolic factors: central adiposity, type 2 diabetes, insulin resistance and dyslipidaemia commonly raise GGTP modestly. In South Asians this can occur at a lower BMI than expected.
- Non-liver conditions: heart failure with hepatic congestion, hyperthyroidism, pancreatic and some other conditions can raise GGTP.
- Herbal and supplement use: AYUSH products, unlabelled weight-loss preparations and gym supplements are a well-recognised cause of enzyme elevation in India.
- Individual variation: some healthy people simply sit above the population reference interval.
Causes of a falsely reassuring or low GGTP
- Established but quiescent liver disease: compensated cirrhosis and chronic viral hepatitis can present with normal enzymes.
- Early or mild steatotic liver disease often produces normal GGTP.
- Some inherited cholestatic disorders cause cholestasis with a characteristically normal GGTP, so a normal value does not exclude cholestasis, especially in children.
- Timing: a sample taken after an injury has resolved may be normal even though a significant episode occurred.
Laboratory factors also matter. Haemolysed samples, long delays in processing and differences in assay method between laboratories can shift values, which is why serial monitoring is best done at the same laboratory where possible.
Risks and safety
Venous blood sampling
Drawing blood for a GGTP test is a low-risk, routine procedure. Possible effects include brief pain, bruising, a small haematoma, light-headedness or fainting, and rarely local infection or nerve irritation. Tell the phlebotomist if you have fainted during blood tests before, are on blood thinners, or have a bleeding disorder.
Repeated monitoring
Frequent sampling during drug monitoring carries the same minor risks, with more bruising over time. Results vary depending on individual clinical circumstances.
Risk of over-interpretation
The commonest harm from this test is not physical. A mildly raised GGTP in a well person can lead to anxiety, repeated tests and unnecessary imaging. Discuss whether the result changes management before pursuing further investigation.
Red flags
Emergency: seek care now
- Confusion, drowsiness, disorientation or altered behaviour in someone with known liver disease
- Vomiting blood, or black tarry stools
- Severe upper abdominal pain with high fever and chills
- Rapidly deepening jaundice with breathlessness or very low urine output
- Easy bleeding or bruising with jaundice
Same-day medical review
- New yellowing of the eyes or skin, dark urine or pale stools
- Persistent vomiting with right upper abdominal pain
- Fever with abnormal liver tests while on anti-tubercular therapy or a new medicine
- Marked itching with jaundice
- New abdominal swelling or rapidly increasing ankle oedema
Routine appointment
- A mildly raised GGTP with no symptoms
- Persistently raised GGTP over months, for risk-factor review and fibrosis assessment
- Long-term fatigue, mild right-sided abdominal discomfort or known fatty liver on ultrasound
- Planning to review herbal or supplement use with a doctor
Special situations
Pregnancy
ALP rises normally in pregnancy from placental production, so a high ALP with a normal GGTP is often physiological. A genuinely raised GGTP in pregnancy needs assessment, particularly where intrahepatic cholestasis of pregnancy or pre-eclampsia-related liver involvement is being considered. Bile acids, not GGTP, are the key test for cholestasis of pregnancy.
Children
Neonatal and infant GGTP values are physiologically much higher and fall through early childhood. In infants with jaundice, GGTP helps distinguish biliary from other causes, but a normal GGTP does not exclude cholestasis. Paediatric hepatology input is important.
Older adults
Polypharmacy, heart failure and bone disease are all common, so an isolated GGTP or ALP abnormality more often reflects one of these than primary liver disease. Medicine review is usually the first step.
Diabetes on glucose-lowering treatment
Raised GGTP is common in type 2 diabetes and often reflects steatotic liver disease. This affects long-term cardiovascular and liver risk and warrants fibrosis assessment rather than only repeat enzyme tests. Do not alter diabetes medicines based on a GGTP result; discuss it with your prescriber.
Chronic kidney disease and dialysis
People with CKD frequently have raised ALP from bone and mineral disease. Here GGTP is particularly useful, because a normal GGTP with high ALP supports a bone rather than a liver source.
Heart failure
Hepatic congestion raises GGTP and ALP. The pattern may improve as cardiac decompensation is treated, so results should be interpreted against the cardiac status at the time of sampling.
People on anti-tubercular therapy
Liver enzyme abnormalities are common on treatment for tuberculosis. Never stop or alter anti-tubercular medicines on your own; the treating doctor decides, based on the pattern, symptoms and bilirubin, whether a drug interruption is needed.
The GGTP test in the Indian context
- Nomenclature on Indian reports: the same panel may be printed as "GGT", "GGTP" or "Gamma GT", with SGPT and SGOT used far more often than ALT and AST. These are the same tests.
- Steatotic liver disease is common, and the terminology has changed: NAFLD is now MASLD, NASH is now MASH, with MetALD describing combined metabolic and alcohol contribution (multi-society Delphi consensus, Rinella et al., 2023). South Asians develop metabolic liver disease at lower body weight than many other populations, so a normal-looking build does not exclude it.
- Drug-induced liver injury from anti-tubercular therapy, unregulated herbal and AYUSH preparations, and gym or weight-loss supplements is an important local cause of abnormal liver enzymes, including GGTP.
- Hepatitis E is a frequent cause of acute hepatitis and jaundice in India, particularly in outbreaks linked to contaminated water; GGTP cannot identify it and serology is required.
- Health-package testing: GGTP is included in many walk-in health check packages. Because mildly raised values are common, a package result is best reviewed with a doctor who knows your history rather than acted on alone.
- Advertising standards: claims of liver "detox" or enzyme-lowering cures are not supported and fall foul of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. No supplement should be taken to "bring GGTP down" without medical advice.
Cost and insurance in India
A standalone GGTP test is one of the less expensive blood tests in India, and it is usually cheaper still when it forms part of a liver function test panel or a health check package than when ordered alone. Prices differ widely between cities, between government and private facilities, and between laboratories.
Factors that influence cost:
- Whether GGTP is ordered alone or within an LFT panel or wider health package
- City and type of facility, government hospital, standalone laboratory, corporate hospital laboratory
- Accreditation status of the laboratory and the assay platform used
- Home sample collection charges and any urgent or after-hours processing fee
- Whether an outpatient consultation fee is charged alongside the test
- Additional tests that follow, such as ultrasound, viral serology or elastography
Insurance: outpatient diagnostic tests are often not covered under standard indemnity health insurance policies unless the policy includes outpatient or diagnostic benefits, or the test is done during an admissible hospital admission. Some corporate and government schemes cover routine investigations. Check your policy wording or with your insurer before assuming reimbursement.
Myths and facts
| Myth | Fact |
|---|---|
| A high GGTP means the person drinks alcohol. | Alcohol is one cause among many. Fatty liver, diabetes, medicines, biliary disease, heart failure and normal variation all raise GGTP. It is not an alcohol test. |
| A normal GGTP means the liver is healthy. | Cirrhosis, chronic hepatitis B or C and fibrotic MASLD can all occur with normal liver enzymes. |
| GGTP can detect liver cancer. | GGTP is not a tumour marker and cannot detect or exclude a liver mass. Imaging is required. |
| A slightly high GGTP needs urgent treatment. | Mild isolated elevation is common and often needs only risk-factor review and a repeat test. Urgency depends on symptoms, bilirubin and the overall pattern. |
| Liver detox drinks or supplements lower GGTP. | No such product is proven to do this, and some herbal and supplement products themselves injure the liver. |
| GGTP tells you how scarred the liver is. | Enzyme levels do not measure fibrosis. Fibrosis scores and elastography are used for that. |
Frequently asked questions
What does a GGTP blood test actually measure?
The GGTP test measures the activity of gamma-glutamyl transpeptidase in your blood serum, reported in U/L. This enzyme is concentrated in liver and bile duct cells, so the level rises when the biliary system is irritated, obstructed, or when certain medicines increase enzyme production.
Do I need to fast before a GGTP test?
Fasting is usually not needed for GGTP alone. If your GGTP test is combined with a lipid profile or fasting glucose, your laboratory may request an overnight fast. Instructions differ between units, so follow the specific advice given by your laboratory or doctor.
How long does the GGTP test take?
The blood draw itself takes only a couple of minutes. Most people spend roughly 10 to 20 minutes at the collection centre including registration and waiting. Report availability differs between laboratories; ask your collection centre directly when the result will be ready.
How high is "too high" for GGTP?
There is no single figure. Reference intervals differ by laboratory, assay method, sex and age, so your report's own printed range applies. What matters more than the number is the pattern with ALP, ALT (SGPT), AST (SGOT) and bilirubin, plus your symptoms and medicine history.
What is the difference between GGTP and SGPT?
SGPT (ALT) mainly reflects injury to liver cells. GGTP mainly reflects bile duct irritation or enzyme induction and is more sensitive but much less specific. They answer different questions, which is why both appear in a liver function panel rather than one replacing the other.
Can stress, exercise or smoking affect GGTP?
Smoking is associated with modestly higher GGTP levels. Intense exercise affects AST more than GGTP. Psychological stress alone is not an established cause of a significant GGTP rise. Recent alcohol intake and certain medicines have far more effect than any of these.
My GGTP is high but my ultrasound is normal. What next?
A normal ultrasound (USG abdomen) does not exclude liver disease, it can miss mild fat and cannot show fibrosis. Your doctor will usually review medicines, herbal products and alcohol, check metabolic risk factors and viral serology, consider a fibrosis score, and repeat the panel.
Can a high GGTP come back to normal?
Yes, often. GGTP frequently falls once a contributing factor is addressed, stopping an implicated supplement under medical guidance, reducing alcohol, treating heart failure, or improving metabolic control. Persistent elevation over months needs evaluation for chronic liver disease rather than repeated testing alone.
Should I stop my medicines before a GGTP test?
No. Do not stop, start or change any prescribed medicine to prepare for this test. Instead, give your doctor a full list of prescription drugs, ayurvedic and herbal preparations and supplements, so the result can be interpreted correctly against what you are taking.
Sources
- American Association for the Study of Liver Diseases (AASLD), guidance on evaluation of abnormal liver chemistries.
- American College of Gastroenterology, clinical guideline on evaluation of abnormal liver chemistries.
- European Association for the Study of the Liver (EASL), clinical practice guidelines on cholestatic liver diseases and on drug-induced liver injury.
- Rinella ME et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature (MASLD, MASH, MetALD), 2023.
- World Health Organization, guidance on hepatitis B, hepatitis C and hepatitis E.
- Central TB Division, Ministry of Health and Family Welfare, India, National TB Elimination Programme guidance on drug-induced hepatotoxicity monitoring.
